Angelo Lombardo (A Lombardo)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Low Density Lipoprotein

Top Venues

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627 (8003) (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627 (8003) (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627 (8003) (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627 (8003) (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627 (8003) (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627 (8003) (2024)
Martino Alfredo Cappelluti, Valeria Mollica Poeta, Sara Valsoni, Piergiuseppe Quarato, Simone Merlin, Ivan Merelli, Angelo Lombardo
Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature (2024)
Carolina Caserta, Silvia Nucera, Matteo Barcella, Grazia Fazio, Matteo Maria Naldini, Riccardo Pagani, Francesca Pavesi, Giacomo Desantis, Erika Zonari, Mariella D'Angiò, Paola Capasso, Angelo Lombardo, Ivan Merelli, Orietta Spinelli, Alessandro Rambaldi, Fabio Ciceri, Daniela Silvestri, Maria Grazia Valsecchi, Andrea Biondi, Giovanni Cazzaniga, Bernhard Gentner
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease. Leukemia (2023)
Anna Maria Sole Giordano, Marco Luciani, Francesca Gatto, Monah Abou-Alezz, Chiara Beghè, Lucrezia Della Volpe, Alessandro Migliara, Sara Valsoni, Marco Genua, Monika Dzieciatkowska M, Giacomo Frati, Julie Tahraoui-Bories, Silvia Clara Giliani, Simona Orcesi, Elisa Fazzi, Renato Ostuni, Angelo D'Alessandro, Raffaella Di Micco, Ivan Merelli, Angelo Lombardo, Martin A M Reijns, Natalia Gromak, Angela Gritti, Anna Kajaste-Rudnitski
DNA damage contributes to neurotoxic inflammation in Aicardi-Goutières syndrome astrocytes. The Journal of experimental medicine 219 (4) (2022)
Matteo Zoccolillo, Immacolata Brigida, Federica Barzaghi, Serena Scala, Raisa Jofra Hernández, Luca Basso-Ricci, Mariasilvia Colantuoni, Emanuela Pettinato, Lucia Sergi Sergi, Giulia Milardi, Paola Capasso, Angelo Lombardo, Silvia Gregori, Francesca Sanvito, Francesca Schena, Simone Cesaro, Francesca Conti, Andrea Pession, Fabio Benedetti, Marco Gattorno, Pui Y Lee, Luigi Naldini, Maria Pia Cicalese, Alessandro Aiuti, Alessandra Mortellaro
Lentiviral correction of enzymatic activity restrains macrophage inflammation in adenosine deaminase 2 deficiency. Blood advances 5 (16) (2021)
A Scotto Rosato, S Montefusco, C Soldati, Simone Di Paola, A Capuozzo, J Monfregola, E Polishchuk, A Amabile, C Grimm, Angelo Lombardo, Maria Antonietta De Matteis, Andrea Balabio, Diego Luis Medina
TRPML1 links lysosomal calcium to autophagosome biogenesis through the activation of the CaMKKβ/VPS34 pathway. Nature communications 10 (1) (2019)
David T Scadden, Samuele Ferrari, Anthony Conway, Aurélien Jacob, Valentina Capo, Luisa Albano, Tiziana Plati, Maria C Castiello, Francesca Sanvito, Andrew R Gennery, Chiara Bovolenta, Rahul Palchaudhuri, David T Scadden, Michael C Holmes, Anna Villa, Giovanni Sitia, Angelo Lombardo, Pietro Genovese, Luigi Naldini
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Science translational medicine 9 (411) (2018)